nodes	percent_of_prediction	percent_of_DWPC	metapath
Rizatriptan—Melatonin—CYP19A1—uterine cancer	0.00648	0.521	CrCbGaD
Rizatriptan—Melatonin—ESR1—uterine cancer	0.00596	0.479	CrCbGaD
Rizatriptan—HTR1B—artery—uterine cancer	0.00507	0.178	CbGeAlD
Rizatriptan—HTR1D—artery—uterine cancer	0.00491	0.173	CbGeAlD
Rizatriptan—MAOA—myometrium—uterine cancer	0.00181	0.0635	CbGeAlD
Rizatriptan—Oedema—Dactinomycin—uterine cancer	0.0017	0.00177	CcSEcCtD
Rizatriptan—Dry eye—Doxorubicin—uterine cancer	0.00165	0.00172	CcSEcCtD
Rizatriptan—Diarrhoea—Progesterone—uterine cancer	0.00165	0.00172	CcSEcCtD
Rizatriptan—Anorexia—Dactinomycin—uterine cancer	0.00162	0.00169	CcSEcCtD
Rizatriptan—Flushing—Etoposide—uterine cancer	0.00161	0.00168	CcSEcCtD
Rizatriptan—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00161	0.00167	CcSEcCtD
Rizatriptan—Photosensitivity—Epirubicin—uterine cancer	0.0016	0.00167	CcSEcCtD
Rizatriptan—Dizziness—Progesterone—uterine cancer	0.00159	0.00166	CcSEcCtD
Rizatriptan—Angiopathy—Etoposide—uterine cancer	0.00157	0.00164	CcSEcCtD
Rizatriptan—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00156	0.00163	CcSEcCtD
Rizatriptan—Eye pain—Epirubicin—uterine cancer	0.00155	0.00162	CcSEcCtD
Rizatriptan—Chills—Etoposide—uterine cancer	0.00155	0.00162	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00155	0.00162	CcSEcCtD
Rizatriptan—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00154	0.00161	CcSEcCtD
Rizatriptan—Vomiting—Progesterone—uterine cancer	0.00153	0.00159	CcSEcCtD
Rizatriptan—Rash—Progesterone—uterine cancer	0.00152	0.00158	CcSEcCtD
Rizatriptan—Dermatitis—Progesterone—uterine cancer	0.00152	0.00158	CcSEcCtD
Rizatriptan—Headache—Progesterone—uterine cancer	0.00151	0.00157	CcSEcCtD
Rizatriptan—Hot flush—Epirubicin—uterine cancer	0.0015	0.00156	CcSEcCtD
Rizatriptan—Increased appetite—Epirubicin—uterine cancer	0.00149	0.00156	CcSEcCtD
Rizatriptan—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00149	0.00156	CcSEcCtD
Rizatriptan—Menopausal symptoms—Epirubicin—uterine cancer	0.00149	0.00155	CcSEcCtD
Rizatriptan—Photosensitivity—Doxorubicin—uterine cancer	0.00148	0.00154	CcSEcCtD
Rizatriptan—Decreased appetite—Dactinomycin—uterine cancer	0.00148	0.00154	CcSEcCtD
Rizatriptan—Dysgeusia—Etoposide—uterine cancer	0.00148	0.00154	CcSEcCtD
Rizatriptan—Fatigue—Dactinomycin—uterine cancer	0.00147	0.00153	CcSEcCtD
Rizatriptan—Pain—Dactinomycin—uterine cancer	0.00145	0.00152	CcSEcCtD
Rizatriptan—Anaphylactoid reaction—Epirubicin—uterine cancer	0.00145	0.00151	CcSEcCtD
Rizatriptan—Muscle spasms—Etoposide—uterine cancer	0.00145	0.00151	CcSEcCtD
Rizatriptan—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00144	0.0015	CcSEcCtD
Rizatriptan—HTR1A—renal system—uterine cancer	0.00144	0.0506	CbGeAlD
Rizatriptan—Eye pain—Doxorubicin—uterine cancer	0.00144	0.0015	CcSEcCtD
Rizatriptan—Cerebrovascular accident—Epirubicin—uterine cancer	0.00143	0.00149	CcSEcCtD
Rizatriptan—Nausea—Progesterone—uterine cancer	0.00143	0.00149	CcSEcCtD
Rizatriptan—HTR1B—female reproductive system—uterine cancer	0.00143	0.0502	CbGeAlD
Rizatriptan—MAOA—uterine cervix—uterine cancer	0.00141	0.0494	CbGeAlD
Rizatriptan—Osteoarthritis—Epirubicin—uterine cancer	0.0014	0.00146	CcSEcCtD
Rizatriptan—Feeling abnormal—Dactinomycin—uterine cancer	0.0014	0.00146	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00139	0.00145	CcSEcCtD
Rizatriptan—Hot flush—Doxorubicin—uterine cancer	0.00139	0.00145	CcSEcCtD
Rizatriptan—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00139	0.00145	CcSEcCtD
Rizatriptan—HTR1D—female reproductive system—uterine cancer	0.00138	0.0486	CbGeAlD
Rizatriptan—Increased appetite—Doxorubicin—uterine cancer	0.00138	0.00144	CcSEcCtD
Rizatriptan—Menopausal symptoms—Doxorubicin—uterine cancer	0.00138	0.00143	CcSEcCtD
Rizatriptan—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00137	0.00143	CcSEcCtD
Rizatriptan—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00137	0.00143	CcSEcCtD
Rizatriptan—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00137	0.00142	CcSEcCtD
Rizatriptan—Face oedema—Epirubicin—uterine cancer	0.00135	0.00141	CcSEcCtD
Rizatriptan—Vertigo—Etoposide—uterine cancer	0.00135	0.00141	CcSEcCtD
Rizatriptan—Body temperature increased—Dactinomycin—uterine cancer	0.00134	0.0014	CcSEcCtD
Rizatriptan—Abdominal pain—Dactinomycin—uterine cancer	0.00134	0.0014	CcSEcCtD
Rizatriptan—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.00134	0.0014	CcSEcCtD
Rizatriptan—MAOA—decidua—uterine cancer	0.00134	0.0471	CbGeAlD
Rizatriptan—Loss of consciousness—Etoposide—uterine cancer	0.00133	0.00138	CcSEcCtD
Rizatriptan—Cerebrovascular accident—Doxorubicin—uterine cancer	0.00133	0.00138	CcSEcCtD
Rizatriptan—Ataxia—Epirubicin—uterine cancer	0.00132	0.00138	CcSEcCtD
Rizatriptan—Cough—Etoposide—uterine cancer	0.00132	0.00137	CcSEcCtD
Rizatriptan—MAOA—renal system—uterine cancer	0.00131	0.0462	CbGeAlD
Rizatriptan—Convulsion—Etoposide—uterine cancer	0.00131	0.00136	CcSEcCtD
Rizatriptan—Dehydration—Epirubicin—uterine cancer	0.00131	0.00136	CcSEcCtD
Rizatriptan—Hypertension—Etoposide—uterine cancer	0.0013	0.00136	CcSEcCtD
Rizatriptan—Osteoarthritis—Doxorubicin—uterine cancer	0.0013	0.00135	CcSEcCtD
Rizatriptan—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00129	0.00135	CcSEcCtD
Rizatriptan—Chest pain—Etoposide—uterine cancer	0.00128	0.00134	CcSEcCtD
Rizatriptan—MAOA—endometrium—uterine cancer	0.00127	0.0447	CbGeAlD
Rizatriptan—Discomfort—Etoposide—uterine cancer	0.00127	0.00132	CcSEcCtD
Rizatriptan—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.00126	0.00132	CcSEcCtD
Rizatriptan—Nasopharyngitis—Epirubicin—uterine cancer	0.00126	0.00131	CcSEcCtD
Rizatriptan—Face oedema—Doxorubicin—uterine cancer	0.00125	0.00131	CcSEcCtD
Rizatriptan—Hypersensitivity—Dactinomycin—uterine cancer	0.00125	0.00131	CcSEcCtD
Rizatriptan—Gastritis—Epirubicin—uterine cancer	0.00124	0.0013	CcSEcCtD
Rizatriptan—Confusional state—Etoposide—uterine cancer	0.00124	0.00129	CcSEcCtD
Rizatriptan—Muscular weakness—Epirubicin—uterine cancer	0.00124	0.00129	CcSEcCtD
Rizatriptan—Anaphylactic shock—Etoposide—uterine cancer	0.00123	0.00128	CcSEcCtD
Rizatriptan—MAOA—mammalian vulva—uterine cancer	0.00123	0.0432	CbGeAlD
Rizatriptan—Abdominal distension—Epirubicin—uterine cancer	0.00122	0.00127	CcSEcCtD
Rizatriptan—Ataxia—Doxorubicin—uterine cancer	0.00122	0.00127	CcSEcCtD
Rizatriptan—Asthenia—Dactinomycin—uterine cancer	0.00122	0.00127	CcSEcCtD
Rizatriptan—Dysphagia—Epirubicin—uterine cancer	0.00121	0.00126	CcSEcCtD
Rizatriptan—Dehydration—Doxorubicin—uterine cancer	0.00121	0.00126	CcSEcCtD
Rizatriptan—Tachycardia—Etoposide—uterine cancer	0.0012	0.00125	CcSEcCtD
Rizatriptan—Hyperhidrosis—Etoposide—uterine cancer	0.00119	0.00124	CcSEcCtD
Rizatriptan—Angina pectoris—Epirubicin—uterine cancer	0.00118	0.00123	CcSEcCtD
Rizatriptan—Anorexia—Etoposide—uterine cancer	0.00117	0.00122	CcSEcCtD
Rizatriptan—MAOA—uterus—uterine cancer	0.00117	0.0412	CbGeAlD
Rizatriptan—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.00117	0.00122	CcSEcCtD
Rizatriptan—Diarrhoea—Dactinomycin—uterine cancer	0.00116	0.00121	CcSEcCtD
Rizatriptan—Nasopharyngitis—Doxorubicin—uterine cancer	0.00116	0.00121	CcSEcCtD
Rizatriptan—Gastritis—Doxorubicin—uterine cancer	0.00115	0.0012	CcSEcCtD
Rizatriptan—Muscular weakness—Doxorubicin—uterine cancer	0.00115	0.00119	CcSEcCtD
Rizatriptan—Dysuria—Epirubicin—uterine cancer	0.00113	0.00118	CcSEcCtD
Rizatriptan—Abdominal distension—Doxorubicin—uterine cancer	0.00113	0.00118	CcSEcCtD
Rizatriptan—Upper respiratory tract infection—Epirubicin—uterine cancer	0.00113	0.00118	CcSEcCtD
Rizatriptan—Dysphagia—Doxorubicin—uterine cancer	0.00112	0.00117	CcSEcCtD
Rizatriptan—Pollakiuria—Epirubicin—uterine cancer	0.00112	0.00117	CcSEcCtD
Rizatriptan—Photosensitivity reaction—Epirubicin—uterine cancer	0.00111	0.00115	CcSEcCtD
Rizatriptan—Paraesthesia—Etoposide—uterine cancer	0.00111	0.00115	CcSEcCtD
Rizatriptan—Dyspnoea—Etoposide—uterine cancer	0.0011	0.00114	CcSEcCtD
Rizatriptan—CYP1A2—renal system—uterine cancer	0.0011	0.0386	CbGeAlD
Rizatriptan—Somnolence—Etoposide—uterine cancer	0.00109	0.00114	CcSEcCtD
Rizatriptan—Angina pectoris—Doxorubicin—uterine cancer	0.00109	0.00114	CcSEcCtD
Rizatriptan—Vomiting—Dactinomycin—uterine cancer	0.00108	0.00113	CcSEcCtD
Rizatriptan—Rash—Dactinomycin—uterine cancer	0.00107	0.00112	CcSEcCtD
Rizatriptan—Decreased appetite—Etoposide—uterine cancer	0.00107	0.00112	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Etoposide—uterine cancer	0.00106	0.00111	CcSEcCtD
Rizatriptan—Fatigue—Etoposide—uterine cancer	0.00106	0.00111	CcSEcCtD
Rizatriptan—MAOA—female reproductive system—uterine cancer	0.00105	0.037	CbGeAlD
Rizatriptan—Pain—Etoposide—uterine cancer	0.00105	0.0011	CcSEcCtD
Rizatriptan—Constipation—Etoposide—uterine cancer	0.00105	0.0011	CcSEcCtD
Rizatriptan—Dysuria—Doxorubicin—uterine cancer	0.00105	0.00109	CcSEcCtD
Rizatriptan—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.00104	0.00109	CcSEcCtD
Rizatriptan—Sweating—Epirubicin—uterine cancer	0.00104	0.00108	CcSEcCtD
Rizatriptan—Pollakiuria—Doxorubicin—uterine cancer	0.00104	0.00108	CcSEcCtD
Rizatriptan—Photosensitivity reaction—Doxorubicin—uterine cancer	0.00102	0.00107	CcSEcCtD
Rizatriptan—Epistaxis—Epirubicin—uterine cancer	0.00102	0.00106	CcSEcCtD
Rizatriptan—Feeling abnormal—Etoposide—uterine cancer	0.00101	0.00106	CcSEcCtD
Rizatriptan—Nausea—Dactinomycin—uterine cancer	0.00101	0.00105	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Etoposide—uterine cancer	0.00101	0.00105	CcSEcCtD
Rizatriptan—Bradycardia—Epirubicin—uterine cancer	0.000988	0.00103	CcSEcCtD
Rizatriptan—Urticaria—Etoposide—uterine cancer	0.000978	0.00102	CcSEcCtD
Rizatriptan—Abdominal pain—Etoposide—uterine cancer	0.000973	0.00101	CcSEcCtD
Rizatriptan—Body temperature increased—Etoposide—uterine cancer	0.000973	0.00101	CcSEcCtD
Rizatriptan—Hypoaesthesia—Epirubicin—uterine cancer	0.000966	0.00101	CcSEcCtD
Rizatriptan—Pharyngitis—Epirubicin—uterine cancer	0.000964	0.001	CcSEcCtD
Rizatriptan—Sweating—Doxorubicin—uterine cancer	0.000959	0.001	CcSEcCtD
Rizatriptan—MAOA—female gonad—uterine cancer	0.000958	0.0337	CbGeAlD
Rizatriptan—MAOA—vagina—uterine cancer	0.000952	0.0335	CbGeAlD
Rizatriptan—Epistaxis—Doxorubicin—uterine cancer	0.000944	0.000984	CcSEcCtD
Rizatriptan—Bradycardia—Doxorubicin—uterine cancer	0.000915	0.000954	CcSEcCtD
Rizatriptan—Hypersensitivity—Etoposide—uterine cancer	0.000907	0.000945	CcSEcCtD
Rizatriptan—Tinnitus—Epirubicin—uterine cancer	0.000905	0.000944	CcSEcCtD
Rizatriptan—Flushing—Epirubicin—uterine cancer	0.000901	0.00094	CcSEcCtD
Rizatriptan—Hypoaesthesia—Doxorubicin—uterine cancer	0.000894	0.000932	CcSEcCtD
Rizatriptan—Pharyngitis—Doxorubicin—uterine cancer	0.000892	0.00093	CcSEcCtD
Rizatriptan—Asthenia—Etoposide—uterine cancer	0.000883	0.000921	CcSEcCtD
Rizatriptan—Angiopathy—Epirubicin—uterine cancer	0.000881	0.000918	CcSEcCtD
Rizatriptan—Chills—Epirubicin—uterine cancer	0.000871	0.000908	CcSEcCtD
Rizatriptan—Pruritus—Etoposide—uterine cancer	0.000871	0.000908	CcSEcCtD
Rizatriptan—Arrhythmia—Epirubicin—uterine cancer	0.000867	0.000904	CcSEcCtD
Rizatriptan—Mental disorder—Epirubicin—uterine cancer	0.000851	0.000887	CcSEcCtD
Rizatriptan—Erythema—Epirubicin—uterine cancer	0.000845	0.000881	CcSEcCtD
Rizatriptan—Diarrhoea—Etoposide—uterine cancer	0.000842	0.000878	CcSEcCtD
Rizatriptan—Tinnitus—Doxorubicin—uterine cancer	0.000838	0.000873	CcSEcCtD
Rizatriptan—Flushing—Doxorubicin—uterine cancer	0.000834	0.000869	CcSEcCtD
Rizatriptan—Flatulence—Epirubicin—uterine cancer	0.000833	0.000868	CcSEcCtD
Rizatriptan—Tension—Epirubicin—uterine cancer	0.000829	0.000865	CcSEcCtD
Rizatriptan—Dysgeusia—Epirubicin—uterine cancer	0.000828	0.000863	CcSEcCtD
Rizatriptan—Nervousness—Epirubicin—uterine cancer	0.000821	0.000856	CcSEcCtD
Rizatriptan—Angiopathy—Doxorubicin—uterine cancer	0.000815	0.00085	CcSEcCtD
Rizatriptan—Dizziness—Etoposide—uterine cancer	0.000814	0.000848	CcSEcCtD
Rizatriptan—Muscle spasms—Epirubicin—uterine cancer	0.000813	0.000847	CcSEcCtD
Rizatriptan—Chills—Doxorubicin—uterine cancer	0.000806	0.00084	CcSEcCtD
Rizatriptan—Arrhythmia—Doxorubicin—uterine cancer	0.000803	0.000837	CcSEcCtD
Rizatriptan—Vision blurred—Epirubicin—uterine cancer	0.000797	0.000831	CcSEcCtD
Rizatriptan—Mental disorder—Doxorubicin—uterine cancer	0.000787	0.000821	CcSEcCtD
Rizatriptan—Vomiting—Etoposide—uterine cancer	0.000782	0.000816	CcSEcCtD
Rizatriptan—Erythema—Doxorubicin—uterine cancer	0.000782	0.000815	CcSEcCtD
Rizatriptan—Agitation—Epirubicin—uterine cancer	0.000777	0.00081	CcSEcCtD
Rizatriptan—Rash—Etoposide—uterine cancer	0.000776	0.000809	CcSEcCtD
Rizatriptan—Dermatitis—Etoposide—uterine cancer	0.000775	0.000808	CcSEcCtD
Rizatriptan—Headache—Etoposide—uterine cancer	0.000771	0.000804	CcSEcCtD
Rizatriptan—Flatulence—Doxorubicin—uterine cancer	0.000771	0.000803	CcSEcCtD
Rizatriptan—Tension—Doxorubicin—uterine cancer	0.000767	0.0008	CcSEcCtD
Rizatriptan—Dysgeusia—Doxorubicin—uterine cancer	0.000766	0.000799	CcSEcCtD
Rizatriptan—Nervousness—Doxorubicin—uterine cancer	0.00076	0.000792	CcSEcCtD
Rizatriptan—Vertigo—Epirubicin—uterine cancer	0.000759	0.000792	CcSEcCtD
Rizatriptan—Syncope—Epirubicin—uterine cancer	0.000758	0.00079	CcSEcCtD
Rizatriptan—Muscle spasms—Doxorubicin—uterine cancer	0.000752	0.000784	CcSEcCtD
Rizatriptan—Palpitations—Epirubicin—uterine cancer	0.000747	0.000779	CcSEcCtD
Rizatriptan—Loss of consciousness—Epirubicin—uterine cancer	0.000743	0.000775	CcSEcCtD
Rizatriptan—Cough—Epirubicin—uterine cancer	0.000738	0.000769	CcSEcCtD
Rizatriptan—Vision blurred—Doxorubicin—uterine cancer	0.000737	0.000768	CcSEcCtD
Rizatriptan—Convulsion—Epirubicin—uterine cancer	0.000732	0.000764	CcSEcCtD
Rizatriptan—Nausea—Etoposide—uterine cancer	0.000731	0.000762	CcSEcCtD
Rizatriptan—Hypertension—Epirubicin—uterine cancer	0.00073	0.000761	CcSEcCtD
Rizatriptan—Arthralgia—Epirubicin—uterine cancer	0.00072	0.00075	CcSEcCtD
Rizatriptan—Chest pain—Epirubicin—uterine cancer	0.00072	0.00075	CcSEcCtD
Rizatriptan—Myalgia—Epirubicin—uterine cancer	0.00072	0.00075	CcSEcCtD
Rizatriptan—Agitation—Doxorubicin—uterine cancer	0.000719	0.000749	CcSEcCtD
Rizatriptan—Anxiety—Epirubicin—uterine cancer	0.000717	0.000748	CcSEcCtD
Rizatriptan—Discomfort—Epirubicin—uterine cancer	0.000711	0.000741	CcSEcCtD
Rizatriptan—Dry mouth—Epirubicin—uterine cancer	0.000704	0.000734	CcSEcCtD
Rizatriptan—Vertigo—Doxorubicin—uterine cancer	0.000703	0.000733	CcSEcCtD
Rizatriptan—Syncope—Doxorubicin—uterine cancer	0.000701	0.000731	CcSEcCtD
Rizatriptan—Confusional state—Epirubicin—uterine cancer	0.000696	0.000725	CcSEcCtD
Rizatriptan—Palpitations—Doxorubicin—uterine cancer	0.000691	0.000721	CcSEcCtD
Rizatriptan—Oedema—Epirubicin—uterine cancer	0.00069	0.000719	CcSEcCtD
Rizatriptan—Anaphylactic shock—Epirubicin—uterine cancer	0.00069	0.000719	CcSEcCtD
Rizatriptan—Loss of consciousness—Doxorubicin—uterine cancer	0.000687	0.000717	CcSEcCtD
Rizatriptan—Cough—Doxorubicin—uterine cancer	0.000682	0.000712	CcSEcCtD
Rizatriptan—Shock—Epirubicin—uterine cancer	0.000679	0.000708	CcSEcCtD
Rizatriptan—Convulsion—Doxorubicin—uterine cancer	0.000678	0.000706	CcSEcCtD
Rizatriptan—Nervous system disorder—Epirubicin—uterine cancer	0.000676	0.000705	CcSEcCtD
Rizatriptan—Hypertension—Doxorubicin—uterine cancer	0.000675	0.000704	CcSEcCtD
Rizatriptan—Tachycardia—Epirubicin—uterine cancer	0.000673	0.000702	CcSEcCtD
Rizatriptan—Hyperhidrosis—Epirubicin—uterine cancer	0.000667	0.000695	CcSEcCtD
Rizatriptan—Arthralgia—Doxorubicin—uterine cancer	0.000666	0.000694	CcSEcCtD
Rizatriptan—Chest pain—Doxorubicin—uterine cancer	0.000666	0.000694	CcSEcCtD
Rizatriptan—Myalgia—Doxorubicin—uterine cancer	0.000666	0.000694	CcSEcCtD
Rizatriptan—Anxiety—Doxorubicin—uterine cancer	0.000664	0.000692	CcSEcCtD
Rizatriptan—Discomfort—Doxorubicin—uterine cancer	0.000658	0.000686	CcSEcCtD
Rizatriptan—Anorexia—Epirubicin—uterine cancer	0.000658	0.000686	CcSEcCtD
Rizatriptan—Dry mouth—Doxorubicin—uterine cancer	0.000651	0.000679	CcSEcCtD
Rizatriptan—Confusional state—Doxorubicin—uterine cancer	0.000644	0.000671	CcSEcCtD
Rizatriptan—Anaphylactic shock—Doxorubicin—uterine cancer	0.000638	0.000665	CcSEcCtD
Rizatriptan—Oedema—Doxorubicin—uterine cancer	0.000638	0.000665	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000628	0.000655	CcSEcCtD
Rizatriptan—Shock—Doxorubicin—uterine cancer	0.000628	0.000655	CcSEcCtD
Rizatriptan—Nervous system disorder—Doxorubicin—uterine cancer	0.000626	0.000653	CcSEcCtD
Rizatriptan—Insomnia—Epirubicin—uterine cancer	0.000624	0.000651	CcSEcCtD
Rizatriptan—Tachycardia—Doxorubicin—uterine cancer	0.000623	0.000649	CcSEcCtD
Rizatriptan—Paraesthesia—Epirubicin—uterine cancer	0.000619	0.000646	CcSEcCtD
Rizatriptan—Hyperhidrosis—Doxorubicin—uterine cancer	0.000617	0.000643	CcSEcCtD
Rizatriptan—MAOA—lymph node—uterine cancer	0.000616	0.0217	CbGeAlD
Rizatriptan—Dyspnoea—Epirubicin—uterine cancer	0.000615	0.000641	CcSEcCtD
Rizatriptan—Somnolence—Epirubicin—uterine cancer	0.000613	0.000639	CcSEcCtD
Rizatriptan—Anorexia—Doxorubicin—uterine cancer	0.000608	0.000634	CcSEcCtD
Rizatriptan—Dyspepsia—Epirubicin—uterine cancer	0.000607	0.000633	CcSEcCtD
Rizatriptan—Decreased appetite—Epirubicin—uterine cancer	0.0006	0.000625	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000596	0.000621	CcSEcCtD
Rizatriptan—Fatigue—Epirubicin—uterine cancer	0.000595	0.00062	CcSEcCtD
Rizatriptan—Constipation—Epirubicin—uterine cancer	0.00059	0.000615	CcSEcCtD
Rizatriptan—Pain—Epirubicin—uterine cancer	0.00059	0.000615	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000582	0.000606	CcSEcCtD
Rizatriptan—Insomnia—Doxorubicin—uterine cancer	0.000577	0.000602	CcSEcCtD
Rizatriptan—Paraesthesia—Doxorubicin—uterine cancer	0.000573	0.000598	CcSEcCtD
Rizatriptan—Dyspnoea—Doxorubicin—uterine cancer	0.000569	0.000593	CcSEcCtD
Rizatriptan—Feeling abnormal—Epirubicin—uterine cancer	0.000568	0.000593	CcSEcCtD
Rizatriptan—Somnolence—Doxorubicin—uterine cancer	0.000567	0.000592	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Epirubicin—uterine cancer	0.000564	0.000588	CcSEcCtD
Rizatriptan—Dyspepsia—Doxorubicin—uterine cancer	0.000562	0.000586	CcSEcCtD
Rizatriptan—Decreased appetite—Doxorubicin—uterine cancer	0.000555	0.000578	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000551	0.000575	CcSEcCtD
Rizatriptan—Fatigue—Doxorubicin—uterine cancer	0.00055	0.000574	CcSEcCtD
Rizatriptan—Urticaria—Epirubicin—uterine cancer	0.000548	0.000571	CcSEcCtD
Rizatriptan—Pain—Doxorubicin—uterine cancer	0.000546	0.000569	CcSEcCtD
Rizatriptan—Constipation—Doxorubicin—uterine cancer	0.000546	0.000569	CcSEcCtD
Rizatriptan—Abdominal pain—Epirubicin—uterine cancer	0.000545	0.000569	CcSEcCtD
Rizatriptan—Body temperature increased—Epirubicin—uterine cancer	0.000545	0.000569	CcSEcCtD
Rizatriptan—Feeling abnormal—Doxorubicin—uterine cancer	0.000526	0.000548	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000522	0.000544	CcSEcCtD
Rizatriptan—Hypersensitivity—Epirubicin—uterine cancer	0.000508	0.00053	CcSEcCtD
Rizatriptan—Urticaria—Doxorubicin—uterine cancer	0.000507	0.000529	CcSEcCtD
Rizatriptan—Abdominal pain—Doxorubicin—uterine cancer	0.000505	0.000526	CcSEcCtD
Rizatriptan—Body temperature increased—Doxorubicin—uterine cancer	0.000505	0.000526	CcSEcCtD
Rizatriptan—Asthenia—Epirubicin—uterine cancer	0.000495	0.000516	CcSEcCtD
Rizatriptan—Pruritus—Epirubicin—uterine cancer	0.000488	0.000509	CcSEcCtD
Rizatriptan—Diarrhoea—Epirubicin—uterine cancer	0.000472	0.000492	CcSEcCtD
Rizatriptan—Hypersensitivity—Doxorubicin—uterine cancer	0.00047	0.00049	CcSEcCtD
Rizatriptan—Asthenia—Doxorubicin—uterine cancer	0.000458	0.000477	CcSEcCtD
Rizatriptan—Dizziness—Epirubicin—uterine cancer	0.000456	0.000476	CcSEcCtD
Rizatriptan—Pruritus—Doxorubicin—uterine cancer	0.000452	0.000471	CcSEcCtD
Rizatriptan—Vomiting—Epirubicin—uterine cancer	0.000439	0.000457	CcSEcCtD
Rizatriptan—Diarrhoea—Doxorubicin—uterine cancer	0.000437	0.000455	CcSEcCtD
Rizatriptan—Rash—Epirubicin—uterine cancer	0.000435	0.000453	CcSEcCtD
Rizatriptan—Dermatitis—Epirubicin—uterine cancer	0.000435	0.000453	CcSEcCtD
Rizatriptan—Headache—Epirubicin—uterine cancer	0.000432	0.000451	CcSEcCtD
Rizatriptan—Dizziness—Doxorubicin—uterine cancer	0.000422	0.00044	CcSEcCtD
Rizatriptan—Nausea—Epirubicin—uterine cancer	0.00041	0.000427	CcSEcCtD
Rizatriptan—Vomiting—Doxorubicin—uterine cancer	0.000406	0.000423	CcSEcCtD
Rizatriptan—Rash—Doxorubicin—uterine cancer	0.000402	0.00042	CcSEcCtD
Rizatriptan—Dermatitis—Doxorubicin—uterine cancer	0.000402	0.000419	CcSEcCtD
Rizatriptan—Headache—Doxorubicin—uterine cancer	0.0004	0.000417	CcSEcCtD
Rizatriptan—Nausea—Doxorubicin—uterine cancer	0.000379	0.000395	CcSEcCtD
